Torbjörn Kullenberg

Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment

L. Ranganath, Anna M. Milan, Andrew T. Hughes et al. · Annals of the Rheumatic Diseases · 2014 · 155 citations · Full text

Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes

Torbjörn Kullenberg, Malin Löfqvist, Mika Leinonen et al. · Lara D. Veeken · 2016 · 130 citations · Full text

Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study

Margareta Wikén, B. Hallén, Torbjörn Kullenberg et al. · Clinical Rheumatology · 2018 · 24 citations · Full text

Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin

Bingbing Yang, Brad Gillespie, Brian P. Smith et al. · The Journal of Clinical Pharmacology · 2015 · 15 citations

Inflammation, Translational Medicine, Pharmaceutical Science +15

Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis

Patrick J. Stiff, Mika Leinonen, Torbjörn Kullenberg et al. · Biology of Blood and Marrow Transplantation · 2015 · 14 citations · Full text

Cell Therapy, Immunology, Oral Mucositis +17